| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8445787 | European Journal of Cancer | 2012 | 11 Pages |
Abstract
Denosumab was superior to zoledronic acid in preventing SRE with favourable safety and convenience in patients with bone metastases from advanced cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Allan Lipton, Karim Fizazi, Alison T. Stopeck, David H. Henry, Janet E. Brown, Denise A. Yardley, Gary E. Richardson, Salvatore Siena, Pablo Maroto, Michael Clemens, Boris Bilynskyy, Veena Charu, Philippe Beuzeboc, Michael Rader, Maria Viniegra,